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DEAR EDITOR, Erythropoietic protoporphyria (EPP) is a rare,
inherited disorder of haem biosynthesis, characterized by severe
photosensitivity from early childhood.1 In most countries, no
effective treatment is available and the behavioural adaptations
needed to avoid sunlight, in addition to pain and sleep depriva-
tion associated with phototoxic episodes, are important stressors
in patients with EPP.2 This might be reflected in increased long-
term cortisol levels, which can be measured in scalp hair. Hair
cortisol concentrations (HCC) have previously been shown to
be positively correlated with chronic stress.3 In this study, we
investigated HCC in patients with EPP and the possible relation-
ship with body mass index (BMI), self-reported perceived
stress, quality of life (QoL) and disease severity.
Adults with a confirmed diagnosis of EPP, attending our Por-
phyria Center at the Erasmus Medical Center (Rotterdam, the
Netherlands), were invited to participate in the study. At the
time of inclusion, patients were not receiving any treatment for
EPP. Patients were age- and sex-matched to controls from our
historical cohort4 with a ratio of 1 : 3. Participants with insuffi-
cient hair growth, concomitant disorders of the hypothalamus–
pituitary–adrenal (HPA) axis or continuous exogenous cortico-
steroids use in the past 3 months were excluded.
In both groups, a lock of scalp hair was cut from the poste-
rior vertex and processed for determination of long-term cor-
tisol exposure as described elsewhere.4 We further collected
data on age, sex, BMI, medication use and hair-related factors
in all participants. In addition, the EPP group were asked to fill
out the 14-item Perceived Stress Scale (PSS),5 the EPP-specific
QoL questionnaire (EPP-QoL)6 and to report the time they
could spend in direct sunlight without symptoms.
This study was approved by the local medical ethics com-
mittee and was conducted in accordance with the Declaration
of Helsinki; all participants gave written informed consent.
Statistical analyses were performed with IBM SPPS Statistics
version 21 (IBM, Armonk, NY, U.S.A.). Differences between
groups were assessed with ANCOVA and correlations were tested
using Pearson’s or Spearman’s rho correlation coefficient. The
level of significance was set at a = 005.
Fifteen participants with EPP and 45 controls were included.
There were no significant differences between the groups in
baseline or hair characteristics, except for natural hair colour
(P = 0022). The EPP group had significantly higher HCC than
matched controls [geometric mean, 1706 pg mg1, 95%
confidence interval (CI) 1302–2235 vs. 828 pg mg1, 95%
CI 588–1164, Cohen’s d = 083, P = 0021, Fig. 1]. Adjust-
ments for age, sex and hair colour did not change the results.
Scores on the EPP-QoL, PSS-14 and sunlight sensitivity were
available in nine, 15 and 13 patients, respectively. There was
a strong inverse association between long-term cortisol expo-
sure and EPP-QoL scores (q = 0703, P = 0035). No corre-
lation was found between HCC and PSS scores, or between
HCC and the time that could be spent in sunlight. In the EPP
group, we additionally observed a positive correlation between
HCC and BMI (r = 0672, P = 0012).
In this study, we have demonstrated that patients with EPP
have higher long-term cortisol levels than age- and sex-matched
(a) (b) (c)
Fig 1. Long-term cortisol exposure as measured in scalp hair of study and control participants. Hair cortisol concentrations in the erythropoietic
protoporphyria (EPP) group and the age-and sex-matched control group (a), and their associations with body mass index (BMI) (b) and EPP-
specific quality of life (EPP-QoL) questionnaire score (c) in the EPP group. Hair cortisol concentrations are shown as geometric mean (95%
confidence interval) on a logarithmic scale or as log-transformed data. *P < 005.
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controls and that this was correlated with lower QoL and higher
BMI. Stress in patients with EPP is related to limitations in their
social and professional life, but also to pain from phototoxic
reactions and a deep-rooted fear of sunlight.6 In addition,
reduced light exposure and alterations in the day–night rhythm,
common in these patients,2 could disturb the circadian cortisol
rhythm and induce alterations in HPA-axis activity.
The strong correlation between HCC and scores on the EPP-
QoL suggests that the measurement of hair cortisol could be a
useful addition in the study of EPP and the efficacy of new
treatments, such as afamelanotide,6 as it assesses all aspects of
stress, including biological stress. Furthermore, the association
between HCC and BMI, as found in the EPP group, has previ-
ously been described in other study participants.7,8 It could be
suggested that there is a vicious circle in patients with EPP in
which weight gain because of stress, pain or reduced physical
activity may lead to greater stress-induced cortisol production,
thereby promoting further weight gain.
The main limitation of this study is the small sample size,
which is related to the rarity of EPP.1 Furthermore, we did
not take into consideration the seasonal variance of EPP-related
symptoms or potential seasonal effects on hair cortisol levels
in both groups. Whether EPP-related symptoms affect cortisol
production should be assessed in further studies.
In conclusion, we show that long-term cortisol levels, as
measured in hair, are elevated in patients with EPP and that
these are associated with a lower QoL and higher BMI. Hair
cortisol analysis might be a valuable tool to monitor stress-
related comorbidities and disease-related QoL in patients with
EPP.
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